CRYSTAL POUNCIL: Open Payments
NPI 1336673011 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 50 payments from 18 companies in 2025. Trend: 2023 $616 · 2024 $1,134 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| ABBVIE INC. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Viatris Specialty LLC | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Exact Sciences Corporation | 3 | $52 |
| Corcept Therapeutics | 2 | $48 |
| Corium, LLC | 1 | $27 |
Products named: Ozempic, Kerendia, Wegovy, VRAYLAR, YUPELRI, TRELEGY ELLIPTA, Cologuard Collection Kit, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
